A detailed guide to lipid therapy in intestinal failure
sciencedirect.com shows its articles on its own site.
Read the article on sciencedirect.com ↗Article · Aug 2018 · 1 min read
In brief
In brief
Comprehensive review of intravenous lipid emulsion therapy in pediatric intestinal failure, examining oil source selection, essential fatty acid provision, and prevention of intestinal failure-associated liver disease (IFALD). Discusses clinical risks and benefits of different lipid products for optimizing nutrition support in this population.
Written by the GCMD Library team from the article.
Publication date: August 2018
Source: Seminars in Pediatric Surgery, Volume 27, Issue 4
Author(s): Kathleen M. Gura, McGreggor Crowley
Abstract
Intravenous lipid emulsions are an integral part of nutrition therapy in the intestinal failure patient. In addition to being a concentrated source of non-protein calories, they provide the essential fatty acids necessary for growth and development. Depending upon the oil source used in these products, complications such as intestinal failure associated liver disease (IFALD) can occur. This review will discuss the risks and benefits associated with these products, especially as they relate to the pediatric intestinal failure patient.